Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Self-Pay with Program Discounts Choose longer program durations (8-week or 12-week plans) to get the lowest monthly cost
The dipeptidyl peptidase IV inhibitor vildagliptin suppresses endogenous glucose production and enhances islet function after single-dose administration in type 2 diabetic patients
If you want to find out whether you may qualify for a personalized program, take the free assessment quiz and review your next steps with a licensed provider
Results The numbers of QALYs gained from 2020 to 2040 with increased SGLT2i and GLP-1 RA use in the total population ( n =1.1 million in 2020
US$ 27.32
US$ 21.25
US$ 21.82
